New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:45 EDTINSYInsys Therapeutics price target raised to $99 from $50 at JMP Securities
JMP Securities increased its price target on Insys after the company reported higher than expected earnings. The firm expects the company to benefit from continued growth in its Subsys drug and further advances in its pipeline. JMP Securities reiterates an Outperform rating on the stock.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
08:30 EDTINSYInsys Therapeutics price target raised to $65 from $57 at RBC Capital
Subscribe for More Information
March 3, 2015
07:09 EDTINSYInsys Therapeutics reports Q4 adjusted EPS 53c, consensus 44c
Reports Q4 revenue $66.5M, consensus $63.45M.
February 26, 2015
07:20 EDTINSYInsys Therapeutics cannabidiol receives fast track designation From FDA
Subscribe for More Information
February 24, 2015
07:07 EDTINSYInsys Therapeutics in-licenses novel mast cell therapy for chronic pelvic pain
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use